Skip to main content
NCBI home page
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
. 1987 Apr;23(4):439–445. doi: 10.1111/j.1365-2125.1987.tb03073.x

Age-dependence and free fatty acid modulation of binding kinetics at the benzodiazepine binding site of serum albumin in neonates and adults determined using fast reaction methods.

G Menke, P Pfister, S Sauerwein, I Rietbrock, B G Woodcock, N Rietbrock
PMCID: PMC1386093  PMID: 2437944

Abstract

Binding kinetics at the benzodiazepine binding site of albumin have been determined as a function of age and fatty acid concentration in serum from 32 neonates (umbilical cord blood), 28 adults aged 23-65 years and 24 adults aged 66-101 years using fluorescence-time curves obtained in a Durrum-Gibson stopped-flow apparatus and the specific marker ligand dansylsarcosine. The binding reaction can be described by a 2-step mechanism characterised by four constants: the association rate constant k2 and dissociation rate constant k-2 for the rate limiting step-2; the affinity constant KA' for the formation of an unstable intermediate complex in step-1; the affinity constant KA for the overall reaction. There were marked differences in k2 between the three groups of subjects with highest values occurring in neonates (mean: 296 s-1), intermediate values in adults aged 23-65 years (mean: 200 s-1, P less than 0.001) and lowest values in adults aged 66-101 years (mean: 144 s-1, P less than 0.001). The dissociation rate constants (k-2) averaged 18.5 s-1 overall, showed only minor changes with increasing age and corresponded to dissociation half-lives of 42 ms, 38 ms and 33 ms for neonates, adults 23-65 years and adults 66-101 years respectively. KA' in neonates and in the group of elderly subjects were lower than in adults aged 23-65 years.(ABSTRACT TRUNCATED AT 250 WORDS)

Full text

PDF
439

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Berde C. B., Hudson B. S., Simoni R. D., Sklar L. A. Human serum albumin. Spectroscopic studies of binding and proximity relationships for fatty acids and bilirubin. J Biol Chem. 1979 Jan 25;254(2):391–400. [PubMed] [Google Scholar]
  2. Divoll M., Greenblatt D. J., Harmatz J. S., Shader R. I. Effect of age and gender on disposition of temazepam. J Pharm Sci. 1981 Oct;70(10):1104–1107. doi: 10.1002/jps.2600701004. [DOI] [PubMed] [Google Scholar]
  3. Giacomini K. M., Swezey S. E., Giacomini J. C., Blaschke T. F. Administration of heparin causes in vitro release of non-esterified fatty acids in human plasma. Life Sci. 1980 Sep 1;27(9):771–780. doi: 10.1016/0024-3205(80)90331-8. [DOI] [PubMed] [Google Scholar]
  4. Greenblatt D. J., Abernethy D. R., Locniskar A., Ochs H. R., Harmatz J. S., Shader R. I. Age, sex, and nitrazepam kinetics: relation to antipyrine disposition. Clin Pharmacol Ther. 1985 Dec;38(6):697–703. doi: 10.1038/clpt.1985.248. [DOI] [PubMed] [Google Scholar]
  5. Greenblatt D. J., Divoll M., Puri S. K., Ho I., Zinny M. A., Shader R. I. Clobazam kinetics in the elderly. Br J Clin Pharmacol. 1981 Nov;12(5):631–636. doi: 10.1111/j.1365-2125.1981.tb01281.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Jansen J. A. Kinetics of the binding of salicylazosulfapyridine to human serum albumin. Acta Pharmacol Toxicol (Copenh) 1977 Nov;41(5):401–416. doi: 10.1111/j.1600-0773.1977.tb02151.x. [DOI] [PubMed] [Google Scholar]
  7. Keele D. K., Kay J. L. Plasma free fatty acid and blood sugar levels in newborn infants and their mothers. Pediatrics. 1966 Apr;37(4):597–604. [PubMed] [Google Scholar]
  8. Kragh-Hansen U. Molecular aspects of ligand binding to serum albumin. Pharmacol Rev. 1981 Mar;33(1):17–53. [PubMed] [Google Scholar]
  9. Miyoshi K., Saijo K., Kotani Y., Kashiwagi T., Kawai H. Characteristic properties of fetal human albumin (Alb F) in isomerization equilibrium. Tokushima J Exp Med. 1966 Nov;13(3-4):121–128. [PubMed] [Google Scholar]
  10. Müller W., Wollert U. Characterization of the binding of benzodiazepines to human serum albumin. Naunyn Schmiedebergs Arch Pharmacol. 1973;280(3):229–237. doi: 10.1007/BF00501348. [DOI] [PubMed] [Google Scholar]
  11. Ogburn P. L., Jr, Johnson S. B., Williams P. P., Holman R. T. Levels of free fatty acids and arachidonic acid in pregnancy and labor. J Lab Clin Med. 1980 Jun;95(6):943–949. [PubMed] [Google Scholar]
  12. RODKEY F. L. DIRECT SPECTROPHOTOMETRIC DETERMINATION OF ALBUMIN IN HUMAN SERUM. Clin Chem. 1965 Apr;11:478–487. [PubMed] [Google Scholar]
  13. Rietbrock N., Lassmann A. Stopped-flow studies on drug-protein binding. 1. Kinetics of warfarin binding to human serum albumin. Naunyn Schmiedebergs Arch Pharmacol. 1980 Sep;313(3):269–274. doi: 10.1007/BF00505744. [DOI] [PubMed] [Google Scholar]
  14. Rietbrock N., Menke G., Reuter G., Lassmann A., Schmeidl R. Influence of palmitate and oleate on the binding of warfarin to human serum albumin: stopped-flow studies. J Clin Chem Clin Biochem. 1985 Nov;23(11):719–723. doi: 10.1515/cclm.1985.23.11.719. [DOI] [PubMed] [Google Scholar]
  15. Shimizu S., Tani Y., Yamada H., Tabata M., Murachi T. Enzymatic determination of serum-free fatty acids: a colorimetric method. Anal Biochem. 1980 Sep 1;107(1):193–198. doi: 10.1016/0003-2697(80)90511-4. [DOI] [PubMed] [Google Scholar]
  16. Spector A. A., Santos E. C., Ashbrook J. D., Fletcher J. E. Influence of free fatty acid concentration on drug binding to plasma albumin. Ann N Y Acad Sci. 1973 Nov 26;226:247–258. doi: 10.1111/j.1749-6632.1973.tb20486.x. [DOI] [PubMed] [Google Scholar]
  17. Sudlow G., Birkett D. J., Wade D. N. Further characterization of specific drug binding sites on human serum albumin. Mol Pharmacol. 1976 Nov;12(6):1052–1061. [PubMed] [Google Scholar]
  18. Sudlow G., Birkett D. J., Wade D. N. The characterization of two specific drug binding sites on human serum albumin. Mol Pharmacol. 1975 Nov;11(6):824–832. [PubMed] [Google Scholar]
  19. TROUT D. L., ESTES E. H., Jr, FRIEDBERG S. J. Titration of free fatty acids of plasma: a study of current methods and a new modification. J Lipid Res. 1960 Apr;1:199–202. [PubMed] [Google Scholar]
  20. Wilting J., van der Giesen W. F., Janssen L. H., Weideman M. M., Otagiri M., Perrin J. H. The effect of albumin conformation on the binding of warfarin to human serum albumin. The dependence of the binding of warfarin to human serum albumin on the hydrogen, calcium, and chloride ion concentrations as studied by circular dichroism, fluorescence, and equilibrium dialysis. J Biol Chem. 1980 Apr 10;255(7):3032–3037. [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES